Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-16-421499
Filing Date
2016-01-05
Accepted
2016-01-05 17:22:57
Documents
2
Effectiveness Date
2016-01-05

Document Format Files

Seq Description Document Type Size
1 POS EX d60489dposex.htm POS EX 25772
2 EX-23.3 d60489dex233.htm EX-23.3 1703
  Complete submission text file 0001193125-16-421499.txt   28798
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-208331 | Film No.: 161323714
SIC: 2834 Pharmaceutical Preparations